HOW OUR WEIGHT LOSS PROGRAM WORKS
WHAT ARE GLP-1S?
GLP-1s, such as semaglutide (Ozempic, Rybelsus, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity), are a class of medications used to manage type 2 diabetes. These medications mimic the action of the natural hormone GLP-1, enhancing insulin release, lowering glucose levels, promoting weight loss, and potentially providing cardiovascular benefits. Wegovy, containing semaglutide, is specifically indicated for weight management.
MEASURE YOUR PROGRESS
Our medical team will serve as your dedicated partners in accountability, ensuring that you are on the right track medically and experiencing tangible improvements in your health. Together, we will evaluate your progress using essential health indicators, utilizing tools like our body composition scale and comprehensive lab work that examines crucial markers such as blood sugar and cholesterol levels.
GLP-1S ARE EVIDENCE BASED
These medications, including semaglutide (Wegovy), are considered evidence-based due to rigorous clinical trials leading to FDA approval. In the case of semaglutide, it underwent a comprehensive 68-week double-blinded trial involving nearly 2,000 obese adults without diabetes. The data from this study revealed significant outcomes, with more than 50 percent of participants achieving a 15 percent weight loss, and approximately 40 percent experiencing a remarkable 20 percent reduction in body weight. In contrast, the placebo group showed only about a 2.4 percent decrease in their starting weight. These robust trial results demonstrate the efficacy and evidence-based nature of these medications in promoting weight loss.
HOW DO YOU ADMINISTER?
Semaglutide is administered as a once-a-week subcutaneous (SQ) injection in the belly, to the right or left of the belly button. This injectable can be taken with or without food. The frequency and method of administration depend on the specific GLP-1 agonist and its intended use, whether for managing diabetes or weight loss. Always follow the prescribed dosage and administration instructions provided by healthcare professional and pharmacy.
SIDE EFFECTS
Side effects on GLP-1 agonists are generally well-tolerated and often improve over time with continued medication use. Dosing adjustments, overseen by a medical provider, are typically implemented gradually to minimize gastrointestinal issues. Common side effects may encompass nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, belching, hypoglycemia, flatulence, gastroenteritis, and gastroesophageal reflux disease.
